N A Lopatkin, M F Trapeznikova, E B Mazo, I I Derevianko, A B Sobolevskiĭ, A N Dolzhenok, V V Meshkov
Clinical and bacteriological effects of urotractin are analysed for 60 patients with infectious-inflammatory diseases of the kidney, urinary tracts and prostate treated in 3 urological clinics of Moscow. The drug was given 10 days in a dose 400 mg twice a day. Urotractin demonstrated high efficacy against both gram-negative and gram-positive bacteria. The results were the same in in- and outpatients.
September 1997: Urologii︠a︡ i Nefrologii︠a︡